117 related articles for article (PubMed ID: 12210479)
1. Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.
Hansson J; Bjartell A; Gadaleanu V; Dizeyi N; Abrahamsson PA
Prostate; 2002 Sep; 53(1):50-9. PubMed ID: 12210479
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog.
Tatoud R; Degeorges A; Prévost G; Hoepffner JL; Gauvillé C; Millot G; Thomas F; Calvo F
Mol Cell Endocrinol; 1995 Sep; 113(2):195-204. PubMed ID: 8674827
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
4. Different expression patterns of somatostatin receptor subtypes in cultured epithelial cells from human normal prostate and prostate cancer.
Sinisi AA; Bellastella A; Prezioso D; Nicchio MR; Lotti T; Salvatore M; Pasquali D
J Clin Endocrinol Metab; 1997 Aug; 82(8):2566-9. PubMed ID: 9253335
[TBL] [Abstract][Full Text] [Related]
5. Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.
Dizeyi N; Konrad L; Bjartell A; Wu H; Gadaleanu V; Hansson J; Helboe L; Abrahamsson PA
Urol Oncol; 2002; 7(3):91-8. PubMed ID: 12474541
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation.
Morichetti D; Mazzucchelli R; Santinelli A; Stramazzotti D; Lopez-Beltran A; Scarpelli M; Bono AV; Cheng L; Montironi R
Int J Immunopathol Pharmacol; 2010; 23(2):511-22. PubMed ID: 20646346
[TBL] [Abstract][Full Text] [Related]
7. Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer.
Frati A; Rouzier R; Lesieur B; Werkoff G; Antoine M; Rodenas A; Darai E; Chereau E
Anticancer Res; 2014 Aug; 34(8):3997-4003. PubMed ID: 25075022
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
Reubi JC; Schaer JC; Waser B; Mengod G
Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Xie YM; Yan LN; Wei B; Guo MM; Tang CW
Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
[TBL] [Abstract][Full Text] [Related]
11. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
12. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
13. Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells.
Tsutsumi A; Takano H; Ichikawa K; Kobayashi S; Koike T
Cell Immunol; 1997 Oct; 181(1):44-9. PubMed ID: 9344495
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
[TBL] [Abstract][Full Text] [Related]
15. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Mazzucchelli L; Loetscher P; Kappeler A; Uguccioni M; Baggiolini M; Laissue JA; Mueller C
Am J Pathol; 1996 Aug; 149(2):501-9. PubMed ID: 8701989
[TBL] [Abstract][Full Text] [Related]
17. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
18. Relationship between expression of somatostatin receptors subtype 2 mRNA and estrogen and progesterone receptors in breast cancer.
Zeng X; Yao Z
Chin Med J (Engl); 2003 Dec; 116(12):1850-3. PubMed ID: 14687472
[TBL] [Abstract][Full Text] [Related]
19. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME
J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
